Procollagen Type I Inhibitors
Procollagen Type I inhibitors are chemical compounds that interfere with the synthesis or assembly of procollagen, a precursor molecule to collagen type I. Collagen type I is the most abundant collagen in the human body and is found predominantly in connective tissues such as tendons, ligaments, skin, and bone. The formation of collagen type I begins with the synthesis of procollagen in fibroblasts, where the triple-helical structure is formed through the association of two alpha-1 chains and one alpha-2 chain. This procollagen is then secreted into the extracellular matrix, where specific enzymes cleave the non-helical terminal peptides, resulting in mature collagen fibrils that assemble into larger fibers. Procollagen Type I inhibitors act at various stages in this biosynthetic pathway, potentially affecting transcriptional, translational, or post-translational processes involved in collagen production.
These inhibitors may function through several mechanisms. Some could interfere with the gene expression of COL1A1 and COL1A2, the genes responsible for encoding the alpha-1 and alpha-2 chains of type I procollagen, respectively. Others might inhibit enzymes such as procollagen N- and C-proteinases, which are essential for the removal of the terminal propeptides and the subsequent formation of collagen fibrils. Additionally, certain inhibitors could target post-translational modifications, such as the hydroxylation of proline and lysine residues, a critical step in stabilizing the triple helix structure of procollagen. By impeding these processes, procollagen type I inhibitors can significantly alter the biochemical properties of connective tissues, influencing their structural integrity and mechanical strength.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may downregulate Procollagen Type I expression by activating glucocorticoid receptors leading to the suppression of transcription factors directly involved in the collagen gene's regulation. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline can chelate metal ions, thereby potentially reducing the stability and secretion of Procollagen Type I by interfering with post-translational modification processes that are essential for its maturation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may decrease the synthesis of Procollagen Type I by inhibiting the folate pathway, which is necessary for the production of purine and pyrimidine nucleotides, thus hindering DNA synthesis and cell proliferation including fibroblasts. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram may inhibit the enzyme lysyl oxidase, which is crucial for the cross-linking of collagen molecules, leading to a decrease in mature collagen fibers and, as a consequence, a reduction in Procollagen Type I expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil can inhibit thymidylate synthase, leading to a deficiency in thymidine, one of the four nucleotide bases required for DNA synthesis; this can result in decreased DNA replication and lower Procollagen Type I expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA may activate protein kinase C, which could lead to the phosphorylation of transcription factors that are essential for the transcription of the Procollagen Type I gene, thereby causing a decrease in its expression. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine may competitively inhibit phosphodiesterase, leading to an increase in cyclic AMP levels which could result in a downregulation of Procollagen Type I expression through the alteration of specific cAMP-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, as a tyrosine kinase inhibitor, may prevent the phosphorylation of proteins involved in the signal transduction cascade that leads to the transcription and translation of Procollagen Type I, thereby reducing its expression. | ||||||
3-Aminopropionitrile | 151-18-8 | sc-266473 | 1 g | $104.00 | ||
3-Aminopropionitrile may inhibit the post-translational modification of Procollagen Type I by targeting lysyl oxidase, which is essential for the formation of the mature collagen fibrils, thus leading to a decrease in the secretion of functional collagen fibers. | ||||||
Penicillamine | 52-67-5 | sc-205795 sc-205795A | 1 g 5 g | $46.00 $96.00 | ||
Penicillamine may bind to copper ions, reducing their availability as cofactors for enzymes such as lysyl oxidase that are required for collagen maturation; this can result in diminished cross-linking and a consequent reduction in Procollagen Type I expression. | ||||||